U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 89

1.
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy
Yuqing Wang, Jiang Du, Zhenyue Gao, Haoyang Sun, Mei Mei, Yu Wang, Yu Ren, Xuan Zhou
Br J Cancer. 2023 Mar 30; 128(7): 1196–1207. Published online 2022 Dec 15. doi: 10.1038/s41416-022-02084-y
PMCID:
PMC10050415
AbstractArticlePDF–1.2M
2.
Exome sequencing identifies PD‐L2 as a potential predisposition gene for lymphoma
Jianming Shao, Lei Gao, Marco L. Leung, Bailey Gallinger, Cara Inglese, M. Stephen Meyn, Daniela Del Gaudio, Soma Das, Zejuan Li
Hematol Oncol. 2022 Aug; 40(3): 475–478. Published online 2022 May 29. doi: 10.1002/hon.3033
PMCID:
PMC9546357
AbstractArticlePDF–625K
3.
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tsung-Wei Chen, William Tzu-Liang Chen, Pei-Chen Yang, Tao-Wei Ke, K. S. Clifford Chao
Sci Rep. 2020; 10: 22330. Published online 2020 Dec 18. doi: 10.1038/s41598-020-79419-3
PMCID:
PMC7749140
AbstractArticlePDF–2.7M
4.
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
Friederike Hoffmann, Romina Zarbl, Dennis Niebel, Judith Sirokay, Anne Fröhlich, Christian Posch, Tobias A. W. Holderried, Peter Brossart, Gonzalo Saavedra, Pia Kuster, Sebastian Strieth, Gerrit H. Gielen, Sandra S. Ring, Jörn Dietrich, Torsten Pietsch, Lukas Flatz, Glen Kristiansen, Jennifer Landsberg, Dimo Dietrich
Clin Epigenetics. 2020; 12: 94. Published online 2020 Jun 26. doi: 10.1186/s13148-020-00883-9
PMCID:
PMC7318478
AbstractArticlePDF–1.0M
5.
Cisplatin‐induced programmed cell death ligand‐2 expression is associated with metastasis ability in oral squamous cell carcinoma
Shunichi Sudo, Hiroshi Kajiya, Shinji Okano, Mina Sasaki, Yuri Katsumata, Jun Ohno, Tetsuro Ikebe, Akimitsu Hiraki, Koji Okabe
Cancer Sci. 2020 Apr; 111(4): 1113–1123. Published online 2020 Feb 29. doi: 10.1111/cas.14336
PMCID:
PMC7156784
AbstractArticlePDF–1.0M
6.
The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals
Elliot A. Philips, Antonio Garcia-España, Anna S. Tocheva, Ian M. Ahearn, Kieran R. Adam, Ruimin Pan, Adam Mor, Xiang-Peng Kong
J Biol Chem. 2020 Apr 3; 295(14): 4372–4380. Published online 2019 Dec 27. doi: 10.1074/jbc.AC119.011747
PMCID:
PMC7135984
AbstractArticlePDF–3.2M
7.
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Qingcai Meng, Miaoyan Wei, Bo Zhang, Xianjun Yu, Si Shi
J Immunother Cancer. 2019; 7: 233. Published online 2019 Aug 29. doi: 10.1186/s40425-019-0703-0
PMCID:
PMC6716876
AbstractArticlePDF–6.9M
8.
Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways
Tingting Ren, Bingxin Zheng, Yi Huang, Shidong Wang, Xing Bao, Kuisheng Liu, Wei Guo
Cell Death Dis. 2019 Apr; 10(4): 261. Published online 2019 Mar 18. doi: 10.1038/s41419-019-1497-1
PMCID:
PMC6423010
AbstractArticlePDF–3.9M
9.
Association of a PD-L2 Gene Polymorphism with Chronic Lymphatic Filariasis in a South Indian Cohort
Gopinath Venugopal, Noëlle L. O’Regan, Subash Babu, Ralf R. Schumann, Aparna Srikantam, Roswitha Merle, Susanne Hartmann, Svenja Steinfelder
Am J Trop Med Hyg. 2019 Feb; 100(2): 344–350. Published online 2018 Dec 25. doi: 10.4269/ajtmh.18-0731
PMCID:
PMC6367610
AbstractArticlePDF–121K
10.
Tumor PDCD1LG2 (PD-L2) expression and the lymphocytic reaction to colorectal cancer
Yohei Masugi, Reiko Nishihara, Tsuyoshi Hamada, Mingyang Song, Annacarolina da Silva, Keisuke Kosumi, Mancang Gu, Yan Shi, Wanwan Li, Li Liu, Daniel Nevo, Kentaro Inamura, Yin Cao, Xiaoyun Liao, Katsuhiko Nosho, Andrew T. Chan, Marios Giannakis, Adam J. Bass, F. Stephen Hodi, Gordon J. Freeman, Scott J. Rodig, Charles S. Fuchs, Zhi Rong Qian, Jonathan A. Nowak, Shuji Ogino
Cancer Immunol Res. Author manuscript; available in PMC 2018 Nov 1.
Published in final edited form as: Cancer Immunol Res. 2017 Nov; 5(11): 1046–1055. Published online 2017 Oct 16. doi: 10.1158/2326-6066.CIR-17-0122
PMCID:
PMC5668177
AbstractArticlePDF–1.0M
11.
Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated with PDCD1LG2 Copy Gain
Min Shi, Margaretha GM Roemer, Bjoern Chapuy, Xiaoyun Liao, Heather Sun, Geraldine S. Pinkus, Margaret A. Shipp, Gordon J. Freeman, Scott J. Rodig
Am J Surg Pathol. Author manuscript; available in PMC 2016 Aug 23.
Published in final edited form as: Am J Surg Pathol. 2014 Dec; 38(12): 1715–1723. doi: 10.1097/PAS.0000000000000297
PMCID:
PMC4994970
AbstractArticlePDF–1.4M
12.
Epithelial PD-L2 expression marks Barrett's Esophagus and Esophageal Adenocarcinoma
Sarah Derks, Katie S. Nason, Xiaoyun Liao, Matthew D. Stachler, Kevin X. Liu, Jie Bin Liu, Ewa Sicinska, Michael S. Goldberg, Gordon J. Freeman, Scott J. Rodig, Jon M. Davison, Adam J. Bass
Cancer Immunol Res. Author manuscript; available in PMC 2016 Oct 1.
Published in final edited form as: Cancer Immunol Res. 2015 Oct; 3(10): 1123–1129. Published online 2015 Jun 16. doi: 10.1158/2326-6066.CIR-15-0046
PMCID:
PMC4596773
AbstractArticlePDF–619K
13.
Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
Kazuko Koike, Akinobu Takaki, Takahito Yagi, Yoshiaki Iwasaki, Tetsuya Yasunaka, Hiroshi Sadamori, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Daisuke Sato, Daisuke Nobuoka, Masashi Utsumi, Yasuhiro Miyake, Fusao Ikeda, Hidenori Shiraha, Toshiyoshi Fujiwara, Kazuhide Yamamoto
Transplantation. 2015 Jul; 99(7): 1447–1454. Published online 2015 Jul 6. doi: 10.1097/TP.0000000000000572
PMCID:
PMC4539199
AbstractArticlePDF–1.4M
14.
No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation
Katharina Pfistershammer, Christoph Klauser, Winfried F. Pickl, Johannes Stöckl, Gerhard Zlabinger, Otto Majdic, Peter Steinberger
Eur J Immunol. Author manuscript; available in PMC 2010 Nov 8.
Published in final edited form as: Eur J Immunol. 2006 May; 36(5): 1104–1113. doi: 10.1002/eji.200535344
PMCID:
PMC2975063
AbstractArticlePDF–4.7M
15.
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
Didem Naz Dioken, Ibrahim Ozgul, Irem Yilmazbilek, Mustafa Cengiz Yakicier, Ezgi Karaca, Ayse Elif Erson-Bensan
Cancer Immunol Immunother. 2023 Dec; 72(12): 4065–4075. Published online 2023 Sep 28. doi: 10.1007/s00262-023-03543-y
PMCID:
PMC10991109
AbstractArticlePDF–2.2M
16.
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines
Nyanbol Kuol, Janusz Godlewski, Zbigniew Kmiec, Sara Vogrin, Sarah Fraser, Vasso Apostolopoulos, Kulmira Nurgali
BMC Cancer. 2023; 23: 971. Published online 2023 Oct 12. doi: 10.1186/s12885-023-11410-3
PMCID:
PMC10568879
AbstractArticlePDF–10M
17.
Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment
Jingfang Lv, Zheng Jiang, Junhu Yuan, Meng Zhuang, Xu Guan, Hengchang Liu, Yefeng Yin, Yiming Ma, Zheng Liu, Hongying Wang, Xishan Wang
Front Immunol. 2023; 14: 1093716. Published online 2023 Mar 16. doi: 10.3389/fimmu.2023.1093716
PMCID:
PMC10060638
AbstractArticlePDF–15M
18.
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander
Biomolecules. 2023 Feb; 13(2): 240. Published online 2023 Jan 27. doi: 10.3390/biom13020240
PMCID:
PMC9952948
AbstractArticlePDF–1.7M
19.
FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer
Catherine Davidson, David Taggart, Andrew H. Sims, David W. Lonergan, Marta Canel, Alan Serrels
Br J Cancer. 2022 Nov 9; 127(10): 1893–1905. Published online 2022 Sep 22. doi: 10.1038/s41416-022-01966-5
PMCID:
PMC9643373
AbstractArticlePDF–2.5M
20.
Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations
Marthe Minderman, Avital Amir, Willem Kraan, Esther J. M. Schilder-Tol, Monique E. C. M. Oud, Cornelis G. Scheepstra, Arnold L. Noorduyn, Philip M. Kluin, Marie José Kersten, Marcel Spaargaren, Steven T. Pals
Blood. 2021 Sep 30; 138(13): 1194–1197. doi: 10.1182/blood.2021011366
PMCID:
PMC9632757
Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center